ArticleWorld journal of clinical cases2025
Incidental detection of aortic valve fibroelastomas during endoscopic ultrasound for pancreatic evaluation: Three case reports.
Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPapillary fibroelastomas are rare, benign cardiac tumors typically found on the heart valves. This case series presents three patients with aortic valve fibroelastoma incidentally detected during endoscopic ultrasound (EUS) for pancreatic and biliary pathologies. These cases highly get the potential of EUS in identifying subtle cardiac lesions during gastrointestinal evaluation, raise important questions about the true prevalence of these lesions, and highlight the need for established guidelines for their management and surveillance. The detection of fibroelastomas during routine EUS procedures emphasizes the importance of thorough assessment and multidisciplinary approaches in managing unexpected discoveries. This also highlights the potential thromboembolic risks associated with fibroelastomas and challenges in determining appropriate management strategies for patients who are asymptomatic. CASE SUMMARY: The patients aged 72 years, 51 years, and 42 years underwent EUS for various indications when aortic valve lesions consistent with fibroelastomas were discovered. These findings were subsequently confirmed by transesophageal echocardiography in two cases, with the third patient awaiting assessment. The lesions ranged in size from 0.61 cm to 1.6 cm in diameter and exhibited characteristic sonographic features of fibroelastomas, including hyperechoic appearance and attachment to the aortic valve leaflets. These cases highlight the potential of EUS in identifying subtle cardiac lesions during gastrointestinal evaluation, raising questions about the true prevalence of fibroelastomas and the need for establishing management guidelines.
conclusionThis case series raises important questions regarding the prevalence of aortic valve fibroelastoma lesions in the general population. This highlights the urgent need for comprehensive evidence-based guidelines to standardize the management and long-term surveillance of affected patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.